HIV :: Fixed dose combination drug product lamivudine and zidovudine tablets
The Food and Drug Administration within the U.S. Department of Health and Human Services (HHS/FDA) announced the tentative approval of the fixed-dose combination drug product lamivudine and zidovudine tablets manufactured by Aurobindo Pharma Ltd. of Hyderabad, India.